financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Molson Coors Brewing Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Molson Coors Brewing Company
Apr 30, 2024 5:29 AM

08:05 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain a 12-month target of $75, based on a '25 P/E of 12.3x, a discount to TAP's 10-year mean forward P/E of 16.0x. We raise our adjusted EPS estimates to $6.00 from $5.70 for '24 and to $6.10 from $5.75 for '25. TAP posts Q1 adjusted EPS of $0.95 vs. $0.54 (+76%), well ahead of the $0.75 consensus. The beat was driven by stronger-than-expected sales and margins, as net sales rose 10.7% to $2.60B ($90M ahead of consensus), on improved price/sales mix (+4.4%) and higher financial volumes (+5.7%). Gross margin expanded 430 bps to 37.1% (150 bps above consensus). TAP maintained prior 2024 guidance, but we believe the forecast is likely to prove conservative following the strong Q1 results. TAP also repurchased 1.76M shares for $111M during Q1. We think TAP's results should alleviate concerns about more difficult comps, as its North American market share gains annualize. TAP's recent de-leveraging is notable, as its net debt/TTM EBITDA ratio fell to 2.3x at the end of Q1 versus 3.0x one year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024
11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Jun 11, 2024
03:25 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $990 from $940, reflecting a 51.7x multiple on our 2025 EPS estimate, above LLY's historical forward P/E average. We maintain our 2024 EPS estimate at...
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Jun 11, 2024
01:05 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We set our 12-month target at $65, representing an estimated 2025 P/E of 43.3x. We initiate coverage at Hold, as we see adj-EPS growth to $1.10 in 2024 and $1.50...
Understanding Section 7702 plans
Understanding Section 7702 plans
Jun 11, 2024
Key takeaways Section 7702 of the IRS tax code outlines the criteria that life insurance policies must meet to qualify for tax advantages. The term '7702 plan' is a loose marketing term, not a specific type of life insurance policy. It typically refers to the tax treatment of cash value life insurance policies, which can include whole, universal, variable...
Copyright 2023-2026 - www.financetom.com All Rights Reserved